Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Obese Children

被引:0
作者
Lior Hecht
Ram Weiss
机构
[1] Hadassah - Hebrew University School of Medicine,Department of Human Metabolism and Nutrition and the Section of Pediatric Endocrinology
[2] Hadassah - Hebrew University School of Medicine,Department of Human Metabolism and Nutrition, Braun School of Public Health
来源
Current Diabetes Reports | 2014年 / 14卷
关键词
Nonalcoholic fatty liver disease (NAFLD); Insulin resistance; Insulin clearance; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is commonly found in adults and adolescents with type 2 diabetes (T2DM). The cause–effect relations of these 2 conditions are complex and it is difficult to decipher whether one drives the other or vice versa. Genetic predispositions, along with obesity, are probably shared culprits of both. NAFLD may precede the diagnosis of diabetes and play a critical role of driving its development by way of increasing hepatic and whole body insulin resistance. On the other hand, T2DM is associated with hyperinsulinemia, a resistance to some of the effects of gut derived peptides and increased systemic free fatty acids, that can all promote hepatic lipid deposition. Thus, each condition may promote the development of the other and their mutual presence creates a vicious cycle. Upon studying this complex interplay from another angle, reduction of liver fat significantly improves glucose metabolism in patients with T2DM highlighting the tight pathophysiological link between them.
引用
收藏
相关论文
共 277 条
[1]  
Steinberger J(2009)Progress and challenges in metabolic syndrome in children and adolescents Circulation 119 628-647
[2]  
Daniels SR(2009)Metabolic syndrome in children and adolescents: prevalence, public health issue, and time for initiative J Pediatr Gastroenterol Nutr 49 268-271
[3]  
Eckel RH(2008)Why young adults hold the key to assessing the obesity epidemic in children Arch Pediatr Adolesc Med 162 682-2374
[4]  
Hayman L(2007)Trends in hospitalizations for diabetes among children and young adults: United States, 1993 2004 Diabetes Care 30 3035-1392
[5]  
Lustig RH(2004)Obesity and the metabolic syndrome in children and adolescents N Engl J Med 350 2362-1293
[6]  
McCrindle B(2011)Advances in pediatric nonalcoholic fatty liver disease Pediatr Clin N Am 58 1375-41
[7]  
Kiess W(2009)Advances in pediatric nonalcoholic fatty liver disease Hepatology 50 1282-283
[8]  
Bluher S(2006)Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease Int J Pediatr Obes 1 33-2256
[9]  
Kappellen T(2008)Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease Circulation 118 277-1544
[10]  
Korner A(2012)TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes N Engl J Med 366 2247-897